Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05721677 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CLABSI Prevention With Tissue Adhesive

Study acronym: Cya-No-CLABSI
StatusUnknown
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 2, 2024 (before its estimated March 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
  2. Re-verified, no change to tracked fieldsv5
  3. Trial status: Not Yet Recruiting to Recruitingv4 Show 5 more changesShow less
    • Study sites: 0 to 1
    • Primary completion date: Mar 2, 2026 to Mar 15, 2026
    • Study completion date: Sep 2, 2026 to Sep 15, 2026
    • Start date changed from estimate of Mar 2023 to Mar 15, 2023
    • Eligibility criteria shortened, about 6 words
  4. Primary completion date: Feb 2, 2026 to Mar 2, 2026
    • Start date: Feb 20, 2023 to Mar 2023
    v3
  5. Start date: Feb 2, 2023 to Feb 20, 2023
    • Secondary endpoints revised (12)
    • Eligibility criteria shortened, about 1 word
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Our aim is to test the effect of tissue adhesive application at the Central-line exit-site on CLABSI rates in high-risk pediatric congenital heart disease patients.
Trial Details
NCT Number NCT05721677
Lead Sponsor Rabin Medical Center
Conditions
(from sponsor)		 Central-line Associated Blood Stream Infections (CLABSI)
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov